ELDN
ELDN
NASDAQ · Biotechnology

Eledon Pharmaceuticals Inc

$2.64
-0.01 (-0.38%)
As of Sep 28, 10:17 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +358.0% upside
Low Target $9.42
Average Target $12.09
High Target $15.53
Current Price $2.64
Current
$2.64
Target
$12.09
$9.42 $12.09 avg $15.53
Scenario Analysis
Bear Case
$9.42
256.8%
Low target
Base Case
$12.09
+358.0%
Avg target
Bull Case
$15.53
+488.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.60
-42.6% from high
52-Week Low
$1.35
+95.6% from low
Target vs 52W High
$12.09
+162.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%